Durable Efficacy and Safety of Raltegravir Versus Efavirenz When Combined With Tenofovir/Emtricitabine in Treatment-Naive HIV-1–Infected Patients: Final 5-Year Results From STARTMRK
暂无分享,去创建一个
Y. Yazdanpanah | M. Saag | J. Rockstroh | R. Leavitt | H. Teppler | A. Rodgers | B. Nguyen | J. Lennox | E. Dejesus | M. Dinubile | Michael I. Miller | P. Sklar | H. Wan | Monica L Walker | Michael I. Miller